A Quiz Based On NEJM Scientific References Articles
Settings
Welcome to October ESAT of Scientific references - C3
- 1.Full form of NEJM:
- A.
New Exciting Journal of Medicine
- B.
Non Entertaining Journal of Medicine
- C.
New England Journal of Medicine
- D.
New Epic Journal of Medicine
- 2.Study in NEJM was comparison of efficacy and treatment failure of:
- A.
Amoxyclav and Dicloxacillin
- B.
Amoxyclav and Placebo
- C.
Amoxyclav and Ampicillin
- D.
Amoxyclav and Cefixime
- 3.Objective of the study of Amoxyclav and Placebo - NEJM article is to:
- A.
To evaluate the efficacy & rate of treatment failure in children less than 2 yrears of age, who were suffering from AOM.
- B.
To evaluate the efficacy & rate of treatment failure in children less than 2 yrears of age, who were suffering from SSTI– NEJM article.
- C.
To evaluate the efficacy & rate of treatment failure in children less than 2 yrears of age, who were suffering from UTI– NEJM article.
- D.
To evaluate the efficacy & rate of treatment failure in children less than 2 yrears of age, who were suffering from RTI.
- 4.As per NEJM study of Amoxyclav and Placebo, ____________ % of symptoms was reduced with Amoxyclav on Day 8.
- A.
70%
- B.
100%
- C.
90%
- D.
80%
- 5.Full form of MIC:
- A.
Minimum Inhibitory complex
- B.
Maximum Inhibitory concentration
- C.
Minimum Inhibitory concentration
- D.
Minimum instant concentration
- 6.In MIC study of CEFI O, MIC of cefixime against salmonella Typhi was:
- A.
0.9 mcg /ml
- B.
.09 mcg /ml
- C.
.9 mg/ml
- D.
.09 mg/ml
- 7.MIC of cefixime was reduced to _________ after addition of ofloxacin against Salmonella Typhi:
- A.
.01 mcg/ml
- B.
.1 mcg/ml
- C.
.01mg/ml
- D.
.1 mg/ml
- 8.Against ____________ bacteria causing UTI the MIC of Ofloxacin was reduced by more than 5 times after addition of Cefixime.
- A.
P aeruginosa
- B.
E. Coli
- C.
K. Pneumoniae
- D.
Salmonella Typhi
- 9.Against E.Coli, the MIC of Ofloxacin was reduced by _______ times after addition of Cefixime & that of Cefixime was reduced by _________times after addition of Ofloxacin.
- A.
5 & 2 times
- B.
2 & 5 times
- C.
2 & 2 times
- D.
5 & 5 times
- 10.CEFI -L News letter topic is:
- A.
UTI
- B.
SSTI
- C.
URTI
- D.
LRTI
- 11._________ is the LRTI highlighted in News Letter of CEFI O.
- A.
Pneumonia
- B.
CAP
- C.
Bronchitis
- D.
HAP
- 12.Objective of Finecef CV Study: To evaluate the efficacy & safety of fixed dose combination of Cefpodoxime + Potassium Clavulanate in comparison with Cefuroxime Axetil in patients with:
- A.
Resistance
- B.
LRTI
- C.
URTI
- D.
UTI
- 13.Conclusion of Finecef CV study - Clinical cure rates of Cefpodoxime with Clavulanic acid was:
- A.
57%
- B.
67%
- C.
77%
- D.
87%
- 14.Anafortan KOL Series Issue 4- Camylofin was tried on 4 year old patient suffering from:
- A.
Functional Abdominal pain
- B.
Functional Abdominal pain and Irritable Bowel Syndrome
- C.
Irritable Bowel syndrome
- D.
Abdominal pain due to Dysmennorhoea
- 15.The prevalence of weekly______________ in school going children ranges between 11 –38 % with 3.2 % reporting abdominal pain on a daily basis.
- A.
Headache
- B.
Bodyache
- C.
Abdominal pain
- D.
Diarhoea
Back to top